National Center for Immunization and Respiratory Diseases

Global Adult Vaccine Market Projected to Reach $27.65 Billion by 2028 with a Strong CAGR of 6.01% During 2023-2028 - ResearchAndMarkets.com

Retrieved on: 
星期五, 七月 28, 2023
Biotechnology, Pharmaceutical, AIDS, Oncology, General Health, Health, COVID-19, Infectious Diseases, HIV/AIDS, DPT vaccine, Travel, Prevalence, Public, Disease, Dengue fever, Ministry, Chickenpox, Malaria, NIP, MMR, Vaccination, Infection, UNICEF, CDC, HPV, Growth, Vaccine, Hepatitis, Shingles, National Center for Immunization and Respiratory Diseases, Government, Non-governmental organization, Tuberculosis, Cancer, WHO, HIV, Attenuated vaccine, Korea Disease Control and Prevention Agency, United Kingdom, Immunization, World Health Organization, Country, Neisseria meningitidis

The global adult vaccine market is expected to witness substantial growth, reaching a projected value of US$ 27.65 Billion by 2028, with a strong compound annual growth rate (CAGR) of 6.01% during 2022-2028.

Key Points: 
  • The global adult vaccine market is expected to witness substantial growth, reaching a projected value of US$ 27.65 Billion by 2028, with a strong compound annual growth rate (CAGR) of 6.01% during 2022-2028.
  • Furthermore, government partnerships with biotechnology and pharmaceutical firms to develop new vaccines are contributing to the growth of the adult vaccine market.
  • By Vaccine Type, the adult vaccine market is divided into Influenza, HPV, Zoster, MMR, Pneumococcal, Meningococcal, Hepatitis, Tdap, travel and misc, and varicella.
  • The Adult Vaccine Market is categorized by Vaccinated Population into Influenza, HPV, Zoster, MMR, Meningococcal, Pneumococcal, Hepatitis, Tdap, and Varicella.

Canada's Minister of Health concludes discussions at the G7 Health Ministers' Meeting in Japan

Retrieved on: 
星期一, 五月 15, 2023
National Center for Immunization and Respiratory Diseases, The Honourable, Japan Agency for Medical Research and Development, COVID-19, Infection, Ageing, Global health, Research, AMR, Government, G7, Global Health, Development, Dementia, Health Resources and Services Administration, Climate change, European, Government of Canada, United Kingdom, Policy, CARB-X, Mental health, Safety, Medical research, Medicine, Renewable energy, Pharmaceutical industry, Medical device, Health

From May 13-14, the Honourable Jean-Yves Duclos, Minister of Health, met with G7 partners to consider important global health issues.

Key Points: 
  • From May 13-14, the Honourable Jean-Yves Duclos, Minister of Health, met with G7 partners to consider important global health issues.
  • At the meeting, Minister Duclos emphasized Canada's continued commitment to global health and advocated for more collective attention to human health resources and mental health, as well as equitable sexual and reproductive health and rights.
  • On May 13, the G7 Health Ministers' Meeting held a joint session with G7 Finance Ministers to discuss how the G7 can collaborate effectively and efficiently with international organizations on funding for health emergencies.
  • The G7 Health Ministers' Communiqué outlines global commitments made by G7 partners on strengthening the global health architecture for public health emergencies and contributing to achieving more resilient, equitable and sustainable universal health coverage.

Prevent Blindness Issues Call for Nominations for the 2023 Bonnie Strickland Champion for Children's Vision Award from the NCCVEH

Retrieved on: 
星期四, 五月 11, 2023
National Center for Immunization and Respiratory Diseases, University, ABO, Visual impairment, Research to Prevent Blindness, Mother, NUALS Arts and Literary Annual Meet, Ohio Department of Health, NBCT, Pediatric ophthalmology, Strabismus, University of California, MBA, Vanderbilt University, Bonnie Strickland, Doctor of Philosophy, Utah Division of Services for People with Disabilities, Vision, FAAP, Retirement, Annual general meeting, National Center for Children in Poverty, FACS, Geography, MPH, NYS, Anita Borg Institute Women of Vision Awards, Major Historical and Cultural Site Protected at the National Level, VIP, IEI, Pharmaceutical industry, Birth control, Nursing, Child, Ophthalmology, MD

CHICAGO, May 11, 2023 /PRNewswire-PRWeb/ -- The National Center for Children's Vision and Eye Health at Prevent Blindness (NCCVEH) has issued a call for nominations for the ninth annual "Bonnie Strickland Champion for Children's Vision Award." The award recognizes significant efforts by an individual, or group of individuals, to improve public health approaches for children's vision and eye health at the state or national level. The deadline for submission is July 1, 2023, at noon ET.

Key Points: 
  • CHICAGO, May 11, 2023 /PRNewswire-PRWeb/ -- The National Center for Children's Vision and Eye Health at Prevent Blindness (NCCVEH) has issued a call for nominations for the ninth annual " Bonnie Strickland Champion for Children's Vision Award ."
  • The Bonnie Strickland Champion for Children's Vision Award will be presented at the Annual Meeting of the NCCVEH, to be held virtually on Sept.14, 2023.
  • An all-volunteer committee for the Bonnie Strickland Champion for Children's Vision Award will review all nominations and select the award winner.
  • "We encourage anyone who shares in our sight-saving mission to submit nominations for this year's Bonnie Strickland Champion for Children's Vision Award!"

Insights on Global Cancer Vaccines Market Size & Share Projected to Hit at USD 19.27 Billion and Rise at a CAGR of 14.75% By 2030: Industry Trends, Demand, Value, Analysis & Forecast Report | Facts and Factors

Retrieved on: 
星期二, 二月 7, 2023
National Center for Immunization and Respiratory Diseases, Prostate, Brain, Vaccine, Spinal cord, Woman, Smoking, Government, Hospital, Blood, White blood cell, Cancer, Breast, HPV, Rectum, Leukemia, Immunity, Projection, Tissue, Lymphoma, Radiation, Bone marrow, Lung, Patient, Cancer research, Skin, Bladder cancer, Prostate cancer, Partner (business rank), CNS, Cartilage, Risk, USD, Immune system, Carcinoma, Lung cancer, Vulvar cancer, Central nervous system, Cervical cancer, Classification, Medical imaging, Pharmaceutical industry

The global cancer vaccines market is projected to grow due to the increasing number of types of cancer and the population suffering from such cancers.

Key Points: 
  • The global cancer vaccines market is projected to grow due to the increasing number of types of cancer and the population suffering from such cancers.
  • Based on indication, the global market is divided into bladder cancer, cervical cancer, lung cancer, prostate cancer, and others.
  • List of Key Players in Cancer Vaccines Market:
    Key questions answered in this report:
    What are the growth rate forecast and market size for CANCER VACCINES Market?
  • How can I receive a free copy of the CANCER VACCINES Market sample report and company profiles?

Insights on Global Cancer Vaccines Market Size & Share Projected to Hit at USD 19.27 Billion and Rise at a CAGR of 14.75% By 2030: Industry Trends, Demand, Value, Analysis & Forecast Report | Facts and Factors

Retrieved on: 
星期二, 二月 7, 2023
National Center for Immunization and Respiratory Diseases, Prostate, Brain, Vaccine, Spinal cord, Woman, Smoking, Government, Hospital, Blood, White blood cell, Cancer, Breast, HPV, Rectum, Leukemia, Immunity, Projection, Tissue, Lymphoma, Radiation, Bone marrow, Lung, Patient, Cancer research, Skin, Bladder cancer, Prostate cancer, Partner (business rank), CNS, Cartilage, Risk, USD, Immune system, Carcinoma, Lung cancer, Vulvar cancer, Central nervous system, Cervical cancer, Classification, Medical imaging, Pharmaceutical industry

The global cancer vaccines market is projected to grow due to the increasing number of types of cancer and the population suffering from such cancers.

Key Points: 
  • The global cancer vaccines market is projected to grow due to the increasing number of types of cancer and the population suffering from such cancers.
  • Based on indication, the global market is divided into bladder cancer, cervical cancer, lung cancer, prostate cancer, and others.
  • List of Key Players in Cancer Vaccines Market:
    Key questions answered in this report:
    What are the growth rate forecast and market size for CANCER VACCINES Market?
  • How can I receive a free copy of the CANCER VACCINES Market sample report and company profiles?

Veterinary Vaccine Market Size to Reach USD 13,681.4 Million in 2030| Emergen Research

Retrieved on: 
星期三, 一月 4, 2023
Human, Veterinary medicine, Mortality, USD, Vaccination, Sustainable Development Goals, Lethargy, DVM, RNA, Municipal government in Canada, Student, Dog, University, United Nations Sustainable Development Group, Eli Lilly and Company, Zoonosis, Government, Growth, National Center for Biotechnology Information, CDC, Livestock, Risk, Food security, Disease, National Center for Immunization and Respiratory Diseases, Lead, DNA, Prevalence, Anaphylaxis, Society for the Prevention of Cruelty to Animals, Infection, Centers for Disease Control and Prevention, Clinical and Vaccine Immunology, Fever, Cat, Allergy, Vaccine, Merck & Co., Pet, Society, PETS, Animal, Elanco

VANCOUVER, B.C., Jan. 4, 2023 /PRNewswire/ -- The veterinary vaccine market size reached USD 7,975.3 Million in 2021 and is expected to register a CAGR of 6.2% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, B.C., Jan. 4, 2023 /PRNewswire/ -- The veterinary vaccine market size reached USD 7,975.3 Million in 2021 and is expected to register a CAGR of 6.2% during the forecast period, according to latest analysis by Emergen Research .
  • Increasing adoption of pets, rising prevalence of zoonotic diseases, and surging cases of COVID-19 are some key factors driving veterinary vaccine market revenue growth.
  • According to the report, it was stated that USD 59 million has been allocated to the provincial budget for 2022 to increase the Doctor of Veterinary Medicine (DVM) program.
  • The veterinary vaccine market is expected to register a CAGR of 6.2% over the forecast period and revenue is projected to increase from USD 7,975.3 Million in 2021 to USD 13,681.4 Million in 2030.

Veterinary Vaccine Market Size to Reach USD 13,681.4 Million in 2030| Emergen Research

Retrieved on: 
星期三, 一月 4, 2023
Human, Veterinary medicine, Mortality, USD, Vaccination, Sustainable Development Goals, Lethargy, DVM, RNA, Municipal government in Canada, Student, Dog, University, United Nations Sustainable Development Group, Eli Lilly and Company, Zoonosis, Government, Growth, National Center for Biotechnology Information, CDC, Livestock, Risk, Food security, Disease, National Center for Immunization and Respiratory Diseases, Lead, DNA, Prevalence, Anaphylaxis, Society for the Prevention of Cruelty to Animals, Infection, Centers for Disease Control and Prevention, Clinical and Vaccine Immunology, Fever, Cat, Allergy, Vaccine, Merck & Co., Pet, Society, PETS, Animal, Elanco

VANCOUVER, B.C., Jan. 4, 2023 /PRNewswire/ -- The veterinary vaccine market size reached USD 7,975.3 Million in 2021 and is expected to register a CAGR of 6.2% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, B.C., Jan. 4, 2023 /PRNewswire/ -- The veterinary vaccine market size reached USD 7,975.3 Million in 2021 and is expected to register a CAGR of 6.2% during the forecast period, according to latest analysis by Emergen Research .
  • Increasing adoption of pets, rising prevalence of zoonotic diseases, and surging cases of COVID-19 are some key factors driving veterinary vaccine market revenue growth.
  • According to the report, it was stated that USD 59 million has been allocated to the provincial budget for 2022 to increase the Doctor of Veterinary Medicine (DVM) program.
  • The veterinary vaccine market is expected to register a CAGR of 6.2% over the forecast period and revenue is projected to increase from USD 7,975.3 Million in 2021 to USD 13,681.4 Million in 2030.

CAST Releases a Special Publication on "Zoonotic Diseases in Animal Agriculture and Beyond: A One Health Perspective"

Retrieved on: 
星期一, 十一月 14, 2022
Zoonosis, Animal, University, Occupational safety and health, Nipah virus, Health, Michigan State University, Environment, USDA, United States environmental and occupational health in zoos, Library, Knowledge, MERS, Livestock, Water, Organization, Q&A, National Center for Immunization and Respiratory Diseases, Biophysical environment, Avian influenza, Ohio State University, Agricultural science, Center, Private sector, Investment, Environmental science, Centers for Disease Control and Prevention, George Washington University, Veterinary medicine, COVID-19, Poultry, Human, College of Arts and Sciences, CAST, Thought, Pandemic, Public health, Agricultural Research Service, Food, Emerging, Council, Agriculture, Engineering, Milken Institute School of Public Health, SARS, Medicine, AMES

AMES, Iowa, Nov. 14, 2022  /PRNewswire-PRWeb/ -- The Council for Agricultural Science and Technology's (CAST) new paper, Zoonotic Diseases in Animal Agriculture and Beyond: A One Health Perspective, is now available for free download.

Key Points: 
  • AMES, Iowa, Nov. 14, 2022 /PRNewswire-PRWeb/ -- The Council for Agricultural Science and Technology's (CAST) new paper, Zoonotic Diseases in Animal Agriculture and Beyond: A One Health Perspective, is now available for free download .
  • One Health brings together experts and thinking in biomedicine and health, but goes much further to include animal, environmental, climate sciences, social and behavioral sciences, agriculture, business, engineering, and many more fields.
  • Zoonotic diseases are diseases of animals that infect humans and continue to afflict humanity and animal health and welfare.
  • The special publication, Zoonotic Diseases in Animal Agriculture and Beyond: A One Health Perspective, is available to download on CAST's website.

Worldwide Digital Vaccine Industry to 2027: Growing Technological Advancements are Driving the Market - ResearchAndMarkets.com

Retrieved on: 
星期五, 十月 28, 2022
Health Technology, Health, Medical Supplies, Virtual, Therapy, Diabetes, Conditional sentence, Digital, FriendsLearn, Life, Growth, Internet of things, Devices using Qualcomm Snapdragon processors, Risk, National Center for Immunization and Respiratory Diseases, Bhargav Sri Prakash, Intelligence, Military personnel, Device, Patient, IOT, Telehealth, Degenerative disease, Research, Infection, Tablet, Second Life, Augmented reality, Hospital, Smoking, Cancer, Hypertension, Partnership, Video game, Pharmaceutical industry, Technology

The global digital vaccine market is anticipated to observe impressive growth during the forecast period, 2023-2027.

Key Points: 
  • The global digital vaccine market is anticipated to observe impressive growth during the forecast period, 2023-2027.
  • The major factors include growing incidences of life-related diseases such as chronic diseases, cardiovascular diseases, infectious diseases, and others, and extensive developments in technology, which are driving the growth of the market.
  • Digital vaccine is a subcategory of digital therapeutics which aim to provide medical care by smartphones, tablets, and other devices.
  • Over the past few years, rapid technological advancements in digital therapeutics are augmenting the growth of the market.

Ad Council, AMA, and CDC Urge Flu Vaccinations with "Get My Flu Shot" Campaign

Retrieved on: 
星期三, 十月 12, 2022
Influenza, Medicine, Pharmacy, Family, Centers for Disease Control and Prevention, Unitary state, Lists of disasters, Friends, National Center for Immunization and Respiratory Diseases, Health, Advertising, AMA, World War II, Radio, CDC, Population, Ad Council, YouTube, HHS, MPH, Twitter, Facebook, NEW, Center, Marketing, Season, Government, COVID-19 vaccine, Office of Inspector General, U.S. Department of Health and Human Services, Time, Risk, Hospital, Vaccine, Immunity, Organization, American Medical Association, Technology, History, Immunodeficiency, Euclidean distance, Vaccination, Latinx, Death, Trustee, PSAS, Degenerative disease, Physician, FAQ, Human, MD, Awareness, Social media, Safety, Creativity, Immunization, COVID-19, Conditional sentence, Hurricane Katrina, Public health, Public relations, Bottled water, Sales, Master of Science

NEW YORK, Oct. 12, 2022 /PRNewswire/ -- The Ad Council, American Medical Association (AMA), Centers for Disease Control and Prevention (CDC), and CDC Foundation today launched their annual campaign to motivate more people to get vaccinated against seasonal influenza (flu) to protect themselves and their loved ones.

Key Points: 
  • The campaign ads direct audiences to GetMyFluShot.org for more information, including where to get a flu vaccine in their area.
  • Certain racial and ethnic minority groups also bear an unequal burden of flu hospitalizations and are also less likely to be vaccinated.
  • While we don't know what will happen this flu season, we know that flu vaccination is the most important tool we have to prevent severe flu outcomes.
  • CDC remains committed to emphasizing the benefits of flu vaccination, especially among those groups of people who are disproportionately impacted."